BridgeMD
New treatment option for Neuroendocrine Tumor
Official title An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
ClinicalTrials.gov ID: NCT07132645
What this study is testing
What is Gallium Ga 68-DOTA-FAPI-04?
Gallium Ga 68-DOTA-FAPI-04 is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for neuroendocrine tumor.
Also referred to as 68Ga-DOTA-FAPI-04, 68Ga-FAPi-04.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This early phase I trial determines where and to what degree the tracer [68Ga] Ga-FAPI-04 accumulates in normal and cancer tissues in patients with high grade neuroendocrine cancer. PET is an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of tracer, in the case of this research [68Ga] Ga-FAPI-04.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old
- Current neuroendocrine tumor diagnosis AND high-grade neuroendocrine tumor presentation determined using the following criteria(s):
- Previous low uptake of [68Ga] Ga-DOTATATE PET/CT scan OR
- Krenning Score ≥ 3 OR
- Ki67 index ≥ 20%
You likely can't join if
- Pregnancy or lactation
- Patient recently underwent surgery with wound healing
See the full eligibility criteria
- Age ≥ 18 years old
- Current neuroendocrine tumor diagnosis AND high-grade neuroendocrine tumor presentation determined using the following criteria(s):
- Previous low uptake of [68Ga] Ga-DOTATATE PET/CT scan OR
- Krenning Score ≥ 3 OR
- Ki67 index ≥ 20%
- Able to lie flat for 60 minutes
- Ability to understand and the willingness to sign a written informed consent
- Pregnancy or lactation
- Patient recently underwent surgery with wound healing
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.